24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
UroGen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:39
Full list of Israeli high-tech layoffs in 2026
21:36
Remitly cuts 110 jobs in Israel and closes R&D hub three years after $80 million Rewire acquisition
16:41
Rigas: "Energean needs more gas to compete, and to prevent a monopoly"
16:31
“When you raise walls around data, employees go around them”
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
2
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
3
Cyera employees to sell tens of millions in shares at $9 billion valuation
4
Israeli startup raises $6.2 million to turn social media video into intelligence
5
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
More news
UroGen
5 stories about UroGen
”Exits are not a Strategy. I Never put up a ‘For Sale’ Sign”
23.05.20
|
Sophie Shulman and Golan Hazani
Arie Belldegrun, chairman of UroGen Pharma, talks about catching Covid-19 and gaining FDA approval in the midst of a global pandemic
Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen
24.04.19
|
CTech
The two companies will collaborate on the research of a “therapeutic area of mutual interest”
Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq
24.01.19
|
Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
Sustained Drug Release Company UroGen Submits New Drug Application to FDA
12.07.18
|
Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
Allergan Partners with Urine Incontinence Treatment Company
08.11.17
|
Lilach Baumer
Allergan is conducting clinical trials for a Botox-based bladder treatment, using a sustained release gel developed by Israel-based UroGen